- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07460258
A Study on the Effect of Medical Students' Literature Reading Patterns on Cognitive Load and Academic Writing Ability
March 4, 2026 updated by: Zhongnan Hospital
Compare the effects of three English medical literature reading modes (original text reading, bilingual comparison, full translation) on medical students' accuracy in literature comprehension, perceived cognitive load, mastery of professional terminology, and academic writing ability; assess whether reliance on artificial intelligence translation triggers a 'terminology shortage' phenomenon.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
160
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430071
- Recruiting
- Zhongnan Hospital of Wuhan University
-
Contact:
- Yanru Shen
- Phone Number: 15635609732
- Email: 2017302180062@whu.edu.cn
-
Wuhan, Hubei, China, 430000
- Recruiting
- Zhongnan Hospital of Wuhan University
-
Contact:
- Min Ke, doctor of medicine
- Phone Number: 18672395959
- Email: Keminyk@163.com
-
Wuhan, Hubei, China
- Not yet recruiting
- Zhongnan Hospital
-
Contact:
- Yang Liu, phd
- Phone Number: 18086520318
- Email: drliuyang_eye@whu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Medical students who usually read English literature at school
Description
Inclusion Criteria:
- Students currently enrolled in our school's clinical medicine or related programs. Voluntarily participate and sign the informed consent form.
Exclusion Criteria:
- Native English speakers or those with a background in translation. Previously, they have read the specific literature selected for this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Original text reading
|
|
bilingual comparison
|
|
full text translation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Score for Objective Questions on Literature Comprehension
Time Frame: 1 week
|
Survey to evaluate literature comprehension under various reading modes
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2026
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
June 15, 2026
Study Registration Dates
First Submitted
March 4, 2026
First Submitted That Met QC Criteria
March 4, 2026
First Posted (Actual)
March 10, 2026
Study Record Updates
Last Update Posted (Actual)
March 10, 2026
Last Update Submitted That Met QC Criteria
March 4, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 2026.1.19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.